Use of droxidopa for blood pressure augmentation after acute spinal cord injury: case reports

Use of droxidopa for blood pressure augmentation after acute spinal cord injury: case reports

Hypotension secondary to autonomic dysfunction is a common complication of acute spinal cord injury (SCI) that may worsen neurologic outcomes. Midodrine, an enteral α-1 agonist, is often used to facilitate weaning intravenous (IV) vasopressors, but its use can be limited by reflex bradycardia. Alter...

Full description

Saved in:
Bibliographic Details
Main Authors: Christopher S. Hong, Muhammad K. Effendi, Abdalla A. Ammar, Kent A. Owusu, Mahmoud A. Ammar, Andrew B. Koo, Layton A. Lamsam, Aladine A. Elsamadicy, Gregory A. Kuzmik, Maxwell Laurans, Michael L. DiLuna, Mark L. Landreneau
Format: Article
Language:English
Published: Korean Society of Critical Care Medicine 2025-02-01
Series:Acute and Critical Care
Subjects:
case report
droxidopa
midodrine
spinal cord injury
Online Access:http://www.accjournal.org/upload/pdf/acc-2021-01662.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://www.accjournal.org/upload/pdf/acc-2021-01662.pdf

Similar Items